(Q36335658)

13 August 2017

1 reference

title

Efficacy of mu-opioid agonists in the treatment of evoked neuropathic pain: Systematic review of randomized controlled trials (English)

1 reference

13 August 2017

0 references

0 references

1 reference

Elon Eisenberg

1

1 reference

13 August 2017

Ewan D McNicol

series ordinal

2

1 reference

13 August 2017

Daniel B Carr

series ordinal

3

1 reference

13 August 2017

publication date

5 December 2005

1 reference

13 August 2017

published in

European Journal of Pain

1 reference

13 August 2017

volume

10

1 reference

13 August 2017

issue

8

1 reference

13 August 2017

page(s)

667-676

1 reference

Effects of IV morphine in central pain: a randomized placebo-controlled study

13 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FJ.EJPAIN.2005.10.007

Opioid Therapy for Chronic Pain

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.EJPAIN.2005.10.007

21 January 2018

Chronic neuropathic pain

1 reference

https://api.crossref.org/works/10.1016%2FJ.EJPAIN.2005.10.007

Evidence report on the treatment of pain in cancer patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.EJPAIN.2005.10.007

What decline in pain intensity is meaningful to patients with acute pain?

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.EJPAIN.2005.10.007

Are opioids effective in relieving neuropathic pain?

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.EJPAIN.2005.10.007

Relief of post-herpetic neuralgia with the N-methyl-D-aspartic acid receptor antagonist ketamine: a double-blind, cross-over comparison with morphine and placebo

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.EJPAIN.2005.10.007

Central dysesthesia pain after traumatic spinal cord injury is dependent on N-methyl-D-aspartate receptor activation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.EJPAIN.2005.10.007

Defining the clinically important difference in pain outcome measures

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.EJPAIN.2005.10.007

Clinical importance of changes in chronic pain intensity measured on an 11-point numerical pain rating scale

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.EJPAIN.2005.10.007

Assessing the quality of reports of randomized clinical trials: is blinding necessary?

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.EJPAIN.2005.10.007

Cold allodynia and hyperalgesia in neuropathic pain: the effect of N-methyl-D-aspartate (NMDA) receptor antagonist ketamine--a double-blind, cross-over comparison with alfentanil and placebo

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.EJPAIN.2005.10.007

Opioids in chronic non-cancer pain: systematic review of efficacy and safety

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.EJPAIN.2005.10.007

Opioids for neuropathic pain.

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.EJPAIN.2005.10.007

Concentration-effect relationship of intravenous alfentanil and ketamine on peripheral neurosensory thresholds, allodynia and hyperalgesia of neuropathic pain

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.EJPAIN.2005.10.007

Opioid use in chronic pain

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.EJPAIN.2005.10.007

Nonsteroidal anti-inflammatory drugs, alone or combined with opioids, for cancer pain: a systematic review

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.EJPAIN.2005.10.007

Evaluation and treatment of central pain syndromes

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.EJPAIN.2005.10.007

Both intravenous lidocaine and morphine reduce the pain of postherpetic neuralgia

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.EJPAIN.2005.10.007

Efficacy of pharmacological treatments of neuropathic pain: an update and effect related to mechanism of drug action.

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.EJPAIN.2005.10.007

Multiple mechanisms of secondary hyperalgesia

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.EJPAIN.2005.10.007

Efficacy of oxycodone in neuropathic pain: a randomized trial in postherpetic neuralgia

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.EJPAIN.2005.10.007

Controlled-release oxycodone relieves neuropathic pain: a randomized controlled trial in painful diabetic neuropathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.EJPAIN.2005.10.007

10.1016/J.EJPAIN.2005.10.007

21 January 2018

Identifiers

DOI

1 reference

13 August 2017

1 reference